These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 3576637)

  • 1. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom.
    Teng CM; Kuo YP; Lee LG; Ouyang CH
    Toxicon; 1987; 25(2):201-10. PubMed ID: 3576637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
    Teng CM; Jy W; Ouyang C
    Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a neurotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Prasad BN; Gowda TV
    Toxicon; 1991; 29(11):1345-9. PubMed ID: 1814010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin.
    Dutta S; Gogoi D; Mukherjee AK
    Biochimie; 2015 Mar; 110():93-106. PubMed ID: 25576831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
    Jiang MS; Fletcher JE; Smith LA
    Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro procoagulant and anticoagulant properties of Naja naja naja venom.
    Sundell IB; Rånby M; Zuzel M; Robinson KA; Theakston RD
    Toxicon; 2003 Sep; 42(3):239-47. PubMed ID: 14559074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-enzymatic inhibitors of coagulation and platelet aggregation from Naja nigricollis venom are cardiotoxins.
    Kini RM; Haar NC; Evans HJ
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1012-6. PubMed ID: 3342055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes.
    Tan NH; Arunmozhiarasi A
    Biochem Int; 1989 Oct; 19(4):803-10. PubMed ID: 2619749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Gowda TV
    Toxicon; 1989; 27(8):861-73. PubMed ID: 2781585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of erythrocyte hemolysis kinetics in the purification of complex cardiotoxin mixtures.
    Zusman N; Cafmeyer N; Hudson RA
    Toxicon; 1982; 20(2):517-20. PubMed ID: 7080058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a cardiotoxin from Naja naja kaouthia venom on skeletal muscle: involvement of calcium-induced calcium release, sodium ion currents and phospholipases A2 and C.
    Fletcher JE; Jiang MS; Gong QH; Yudkowsky ML; Wieland SJ
    Toxicon; 1991; 29(12):1489-500. PubMed ID: 1666202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of anticoagulant proteins from cobra venom (Naja nigricollis). Identity with phospholipases A2.
    Evans HJ; Franson R; Qureshi GD; Moo-Penn WF
    J Biol Chem; 1980 Apr; 255(8):3793-7. PubMed ID: 7364769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cobra venom factor: improved method for purification and biochemical characterization.
    Vogel CW; Müller-Eberhard HJ
    J Immunol Methods; 1984 Oct; 73(1):203-20. PubMed ID: 6491300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.
    Rudrammaji LM; Machiah KD; Kantha TP; Gowda TV
    Mol Cell Biochem; 2001 Mar; 219(1-2):39-44. PubMed ID: 11354251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxins from the venom of Malayan cobra (Naja naja sputatrix).
    Tan NH
    Arch Biochem Biophys; 1982 Oct; 218(1):51-8. PubMed ID: 7149742
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of phosphorylation of rat synaptosomal proteins by snake venom phospholipase A2 neurotoxins (beta-bungarotoxin, notexin) and enzymes (Naja naja atra, Naja nigricollis).
    Ueno E; Rosenberg P
    Toxicon; 1990; 28(12):1423-37. PubMed ID: 2089738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of three acidic, cytotoxic phospholipases A2 from Indian cobra (Naja naja naja) venom.
    Rudrammaji LM; Gowda TV
    Toxicon; 1998 Jun; 36(6):921-32. PubMed ID: 9663698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a lethal phospholipase A2 (NN-IVb1-PLA2) from the Indian cobra (Naja naja naja) venom.
    Bhat MK; Gowda TV
    Biochem Int; 1991 Dec; 25(6):1023-34. PubMed ID: 1810247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of platelet effects of cardiotoxins from Naja nigricollis crawshawii (spitting cobra) snake venom.
    Kini RM; Evans HJ
    Thromb Res; 1988 Nov; 52(3):185-95. PubMed ID: 3194895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-bungarotoxin and Naja naja atra snake venom phospholipase A2 on acetylcholine release and choline uptake in synaptosomes.
    Fletcher JE; Middlebrook JL
    Toxicon; 1986; 24(1):91-9. PubMed ID: 3952766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.